Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04886960 · ClinicalTrials.gov registry record · Phase 1
pAF for the Treatment of Osteoarthritis
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT04886960 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 60 participants.
The verdict
NCT04886960, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a Phase I/II Randomized Double-Blinded Standard of Care (Corticosteroid) vs. Sterile Amniotic Fluid for Osteoarthritis
Interventions
- OTHER Standard of Care
- BIOLOGICAL Amniotic Fluid Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-07-08 |
| Est. Completion | 2025-01-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04886960
The ClinicalTrials.gov registry entry for NCT04886960 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04886960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04886960 about?
NCT04886960 is a clinical study titled "pAF for the Treatment of Osteoarthritis". This is a Phase I/II Randomized Double-Blinded Standard of Care (Corticosteroid) vs. Sterile Amniotic Fluid for Osteoarthritis
What is the current status of trial NCT04886960?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2021-07-08. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT04886960?
The interventions under investigation include: Standard of Care (OTHER), Amniotic Fluid Injection (BIOLOGICAL).
Who is sponsoring clinical trial NCT04886960?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.